Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 29, No. 1, 2006   

Free Abstract     Article (References)     Article (PDF 110 KB)     

Original Paper

Cystatin C - A Marker for Assessment of the Glomerular Filtration Rate in Patients with Cisplatin Chemotherapy
P. Benöhra, A. Grenzb, J.T. Hartmannc, G.A. Müllera, S. Blaschkea

aDepartment of Nephrology and Rheumatology, University of Göttingen, Göttingen;
bDepartment of Pharmacology and Toxicology, University of Tübingen, Tübingen, and
cMedical Center II, Department of Hematology and Oncology, Immunology and Rheumatology, Tübingen, Germany

Address of Corresponding Author

Kidney Blood Press Res 2006;29:32-35 (DOI: 10.1159/000092485)


 goto top of page Key Words

  • Cystatin C
  • Creatinine
  • Cisplatin
  • Chemotherapy
  • Glomerular filtration rate
  • Inulin clearance

 goto top of page Abstract

Background: Cystatin C has recently been proposed as an ideal marker for glomerular filtration rate (GFR). In this study, cystatin C serum levels were evaluated in comparison to serum creatinine concentrations and inulin clearances in patients with normal kidney function receiving cisplatin-based chemotherapy to assess the validity of cystatin C as an alternative endogenous marker of GFR. Methods: Blood samples for the assessment of cystatin C, creatinine and inulin clearances were collected in patients before and after application of cisplatin in a clinical trial. Overall, 41 patients were included in the study, 35 of them were eligible receiving cisplatin in two different cisplatin-based chemotherapy schedules. Results: A 21% increase of cystatin C serum levels was demonstrated in the placebo group after application of cisplatin. Analysis of inulin clearances revealed a 23% loss of inulin clearance in patients of the placebo arm. In contrast, significant changes could not be detected by analysis of serum creatinine levels. Conclusions: Cystatin C represents a more sensitive clinical marker than serum creatinine for the early assessment of GFR damage caused by cisplatin. Changes in cystatin C serum concentrations correlate well to GFR decrease as measured by inulin clearance.

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Peter Benöhr, MD
Department of Nephrology and Rheumatology
Georg August University Göttingen, Robert-Koch Strasse 40
DE-37075 Göttingen (Germany)
Tel. +49 551 39 8509, Fax +49 551 39 8507, E-Mail pbenoeh@gwdg.de


 goto top of page Article Information

Received: September 14, 2005
Accepted: January 2, 2006
Published online: March 31, 2006
Number of Print Pages : 4
Number of Figures : 1, Number of Tables : 1, Number of References : 14

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16582575)
Download Citation
Cited In



New KBPR Award
More information: PDF

This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues



For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2010 S. Karger AG, Basel